Hypokalaemia and peripheral oedema in a Cushingoid patient with metastatic prostate cancer

被引:0
|
作者
Schepers, L. M. [1 ]
Kisters, J. M. H. [1 ]
Wetzels, C. [2 ]
Creemers, G. J. [1 ]
机构
[1] Catharina Hosp, Dept Internal Med, Eindhoven, Netherlands
[2] Jeroen Bosch Hosp, Dept Pathol, Shertogenbosch, Netherlands
来源
NETHERLANDS JOURNAL OF MEDICINE | 2020年 / 78卷 / 06期
关键词
Cushing's syndrome; ectopic ACTH production; large cell neuroendocrine carcinoma; prostate cancer; NEUROENDOCRINE DIFFERENTIATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on a 75-year-old man with a history of metastatic prostate cancer who presented with haematuria, peripheral oedema, metabolic alkalosis, hypokalaemia, and hypertension. Laboratory evaluation was compatible with the diagnosis of adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome and suggestive of ectopic ACTH production. Pathology of a prostate biopsy specimen showed a large cell neuroendocrine carcinoma (LCNEC) of the prostate. This report describes a case of Cushing's syndrome that was probably caused by ectopic ACTH secretion by a LCNEC of the prostate.
引用
收藏
页码:401 / 403
页数:3
相关论文
共 50 条
  • [41] Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer
    Wright, JL
    Lin, DW
    Dewan, P
    Montgomery, RB
    INTERNATIONAL JOURNAL OF UROLOGY, 2005, 12 (11) : 1012 - 1013
  • [42] Patient and physician preferences for treatments of metastatic castrate resistant prostate cancer
    Castro, E.
    Jones, R.
    Machtens, S.
    Uemura, H.
    Mclaurin, K.
    Yeh, N.
    Payne, S.
    Cain, T.
    Collacott, H.
    Gabriela, F.
    Heidenreich, S.
    Morgans, A.
    EUROPEAN UROLOGY, 2024, 85 : S323 - S324
  • [43] The development of metachronous prostate cancer and chronic myeloid leukemia in a patient with metastatic rectal cancer
    Oztop, I.
    Yaren, A.
    Demirpence, M.
    Alacacioglu, I.
    Tuna, B.
    Piskin, O.
    Yilmaz, U.
    JOURNAL OF BUON, 2008, 13 (02): : 267 - 270
  • [44] Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria
    Bywater, Laura
    Gist, Anthea C.
    Muthalaly, Rahul G.
    Loh, Joanna
    Simpson, Ian
    White, Anthony J.
    Lim, Andy K. H.
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (05) : 232 - 234
  • [47] PROSTATE CANCER 'The prostate' in patients with metastatic prostate cancer: to treat or not to treat?
    Saad, Fred
    NATURE REVIEWS UROLOGY, 2017, 14 (07) : 398 - 399
  • [48] Fatal outcome in a patient with metastatic prostate cancer and acquired severe hypogammaglobulinemia with complete absence of mature peripheral blood B-cells
    Lohr, J
    Mielke, S
    Lübbert, M
    Behringer, D
    IN VIVO, 2003, 17 (05): : 505 - 507
  • [49] Novel prostate cancer patient-derived xenograft models of bone metastatic castrate-resistant prostate cancer
    Jamieson, Christina
    Wu, Christina
    Strasner, Amy
    Woo, Jason R.
    Muldong, Michelle
    Jeong, Young B.
    Liss, Michael A.
    Raheem, Omer
    Yamaguchi, Tomonori
    Leu, Heather
    Marshall, Deborah
    Morris, Sheldon
    Cacalano, Nicholas A.
    Masuda, Koichi
    Jamieson, Catriona H. M.
    Kulidjian, Anna A.
    Kane, Christopher J.
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [50] Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer
    Torii, Shota
    Torii-Goto, Aya
    Tanizawa, Tamaki
    Sakakibara, Takashi
    Oguri, Ryosuke
    Nagase, Haruka
    Nakao, Yuri
    Hirashita, Tomoyuki
    Tanaka, Kuniaki
    Takimoto, Norio
    Hayashi, Takahiro
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01):